血红蛋白浓度影响ICU收治患者的粘弹性止血检测
该研究为观察性队列研究加体外实验室研究,纳入两个急性脑出血队列(分别接受ROTEM n=34和TEG n=239检测)及一个接受ROTEM的外科ICU队列(n=121),评估基线血红蛋白与粘弹性止血检测结果的关系。结果显示血红蛋白与凝血动力学直接相关(ROTEM r=0.46,p=0.01;TEG r=0.49,p<0.0001),与血凝块强度呈负相关(ROTEM r=-0.52,p=0.002;TEG r=-0.40,p<0.0001),围手术期ICU患者中关系类似,体外降低脑出血患者血样血红蛋白后ROTEM同样表现为凝血动力学加快、血凝块强度增大。作者认为这种影响似乎是人为假象,低血红蛋白患者可能粘弹性参数看似正常而实际存在轻度低凝状态,需进一步研究是否应按血红蛋白校正这些检测。
要点
- 在脑出血ROTEM队列(n=34)中,血红蛋白与凝血动力学直接相关(r=0.46,p=0.01),与血凝块强度负相关(r=-0.52,p=0.002)。
- 在脑出血TEG队列(n=239)中,血红蛋白与凝血动力学直接相关(r=0.49,p<0.0001),与血凝块强度负相关(r=-0.40,p<0.0001)。
- 围手术期ICU患者(n=121)中同样识别出上述关系,并在线性回归模型中继续存在。
- 体外将脑出血患者血样调至更低血红蛋白浓度后,ROTEM轨迹显示凝血动力学逐渐加快、血凝块强度增大。
- 作者认为低血红蛋白对ROTEM/TEG的影响似乎是人为假象,低血红蛋白患者可能粘弹性参数看似正常而实际存在轻度低凝状态。
适用人群与场景
- 两个急性脑出血队列:一个接受ROTEM检测(n=34),一个接受TEG检测(n=239)。
- 第三个外科ICU队列接受ROTEM检测(n=121),用于评估跨疾病和检测平台的可推广性。
- 体外ROTEM实验室研究使用脑出血患者血样。
研究设计与关键结果
- 研究设计为观察性队列研究加单独的体外实验室研究,设置在多中心三级转诊ICU。
- 脑出血ROTEM队列(n=34):血红蛋白与凝血动力学直接相关(r=0.46,p=0.01),与血凝块强度负相关(r=-0.52,p=0.002)。
- 脑出血TEG队列(n=239):血红蛋白与凝血动力学直接相关(r=0.49,p<0.0001),与血凝块强度负相关(r=-0.40,p<0.0001)。
- 围手术期ICU患者(n=121)中识别出类似关系,线性回归模型中关系持续存在。
- 体外将脑出血患者血样调至更低血红蛋白浓度后,ROTEM轨迹显示凝血动力学逐渐加快、血凝块强度增大。
证据类型、等级与局限
- 证据类型:观察性队列研究与体外实验室研究。
- 局限:作者指出需进一步研究以确定这些检测是否应按患者血红蛋白浓度进行校正。
对床旁实践的改变
- 作者认为低血红蛋白对ROTEM/TEG的影响似乎是人为假象,低血红蛋白患者可能粘弹性参数看似正常而实际存在轻度低凝状态。
- 作者指出需进一步研究以确定这些检测是否应按患者血红蛋白浓度进行校正。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Low hemoglobin concentration impairs clinical hemostasis across several diseases. It is unclear whether hemoglobin impacts laboratory functional coagulation assessments. We evaluated the relationship of hemoglobin concentration on viscoelastic hemostatic assays in intracerebral hemorrhage (ICH) and perioperative patients admitted to an ICU.
DESIGN: Observational cohort study and separate in vitro laboratory study.
SETTING: Multicenter tertiary referral ICUs.
PATIENTS: Two acute ICH cohorts receiving distinct testing modalities: rotational thromboelastometry (ROTEM) and thromboelastography (TEG), and a third surgical ICU cohort receiving ROTEM were evaluated to assess the generalizability of findings across disease processes and testing platforms. A separate in vitro ROTEM laboratory study was performed utilizing ICH patient blood samples.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Relationships between baseline hemoglobin and ROTEM/TEG results were separately assessed across patient cohorts using Spearman correlations and linear regression models. A separate in vitro study assessed ROTEM tracing changes after serial hemoglobin modifications from ICH patient blood samples. In both our ROTEM (n = 34) and TEG (n = 239) ICH cohorts, hemoglobin concentrations directly correlated with coagulation kinetics (ROTEM r: 0.46; p = 0.01; TEG r: 0.49; p < 0.0001) and inversely correlated with clot strength (ROTEM r: -0.52, p = 0.002; TEG r: -0.40, p < 0.0001). Similar relationships were identified in perioperative ICU admitted patients (n = 121). We continued to identify these relationships in linear regression models. When manipulating ICH patient blood samples to achieve lower hemoglobin concentrations in vitro, we similarly identified that lower hemoglobin concentrations resulted in progressively faster coagulation kinetics and greater clot strength on ROTEM tracings.
CONCLUSIONS: Lower hemoglobin concentrations have a consistent, measurable impact on ROTEM/TEG testing in ICU admitted patients, which appear to be artifactual. It is possible that patients with low hemoglobin may appear to have normal viscoelastic parameters when, in fact, they have a mild hypocoagulable state. Further work is required to determine if these tests should be corrected for a patient's hemoglobin concentration.
参考来源
- Roh DJ, Chang TR, Kumar A, et al. Hemoglobin Concentration Impacts Viscoelastic Hemostatic Assays in ICU Admitted Patients. Crit Care Med. 2023. PMID: 36661453. doi:10.1097/CCM.0000000000005700
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。